Kadant Inc. heads into its Q1 results window with short sellers in a clear retreat — but still holding a position meaningful enough to set the tone for the next few weeks.
Short interest has been falling steadily since late March, when it peaked near 13.8% of the free float. It now stands at 12.4% — still elevated for an industrial machinery name, but the direction of travel has been firmly lower. Over the past month shorts trimmed roughly 8% of their position in share terms, with the bulk of the covering happening through April. The past week saw a modest reversal — SI edged up about 2% — suggesting the unwind has at least paused ahead of the May 20 event. The ORTEX short score of 66 is consistent with a well-populated but not extreme short base. On the borrow side, the lending market is notably relaxed: cost to borrow runs at just 0.42% annualised, down roughly 10% on the week, and availability remains ample. There is no squeeze pressure in the current setup.
Options positioning is close to neutral. The put/call ratio sits at 0.58, essentially in line with its 20-day average of 0.58 — a z-score near zero, which implies neither meaningful hedging demand nor unusual call-buying enthusiasm. The 52-week range for PCR runs from 0.25 to 2.71, which puts current readings well within the calm middle of the band. For a stock down 6.7% on the week to $288.86, the absence of defensive options activity is notable — investors appear to be waiting rather than repositioning.
Analyst coverage is thin but consistent. Barrington Research reiterated its Outperform rating and $380 target as recently as May 4, keeping the most bullish voice on the Street active into earnings. DA Davidson holds a Neutral with a $295 target, close to the current price. The mean target across coverage sits at $341, implying roughly 18% upside to where the stock is now. The bull case rests on solid bookings momentum — Kadant had reported bookings of $93.6 million, up from $87.4 million a year earlier, with aftermarket parts driving 73% of revenue. That recurring aftermarket component is the structural argument for quality. The bear case flags weaker gross margins from tariff headwinds and an unfavourable product mix, with the more pointed concern being an 18% drop in Segment EBITDA and a sharp decline in adjusted EPS. EV/EBITDA trades at 14.3x, with the multiple broadly flat over the past 30 days despite the price weakness. The PE sits at 24.5x, compressing modestly through the month.
Institutional ownership is largely passive and stable. BlackRock holds 14.7% and added around 14,000 shares in the most recent filing period. Wasatch Advisors added more aggressively — 125,000 shares in the quarter to March 31 — taking their stake to 8.8% of shares outstanding. Brown Advisory and Riverbridge Partners also added meaningfully. Kayne Anderson Rudnick trimmed 27,000 shares, the largest reduction among the top holders. Recent insider activity is routine: director awards in early April and CEO Jeffrey Powell's March stock award were accompanied by a small open-market sale of 1,051 shares at $334, a standard equity-plan disposal rather than a signal of conviction either way.
The stock's last confirmed earnings reaction is instructive. After the Q4 2025 report on April 28, KAI fell 3.2% the next day and dropped 8.7% over the following five sessions — a meaningful post-print selloff that coincided with the bear-case concerns around margins and EPS. Correlated peers showed a mixed week: PLOW surged 12.3% while IR fell 6.6%, closely tracking Kadant's own decline, suggesting sector-wide macro sensitivity rather than a company-specific story. What to watch into May 20 is whether the margin narrative has stabilised — the debate between the bullish bookings trend and the bearish EBITDA compression is where the print will likely be scored.
See the live data behind this article on ORTEX.
Open KAI on ORTEX →ORTEX Market Intelligence content is generated by AI from a snapshot of ORTEX's proprietary data. Content is informational only and does not constitute investment advice.
